7.B radiation induced lymphoma
a 40-year-old man living in Berlin, had been diagnosed with HIV-1 infection 10 years earlier and had been on a suppressive antiretroviral regimen including tenofovir (TDF), emtricitabine (FTC), and efavirenz (EFV) for four years prior to his AML diagnosis. The patient underwent two courses of induction chemotherapy and a single course of consolidation therapy, but his AML relapsed, necessitating HSCT. Due to the foresight of the patient’s hematologist, an HLA-identical donor homozygous for the CCR5Δ32 allele was identified. The patient received anti–thymocyte globulin, cyclophosphamide, and TBI in preparation for the transplant; mycophenylate mofetil and cyclosporine were administered after HSCT to prevent GVHD. Although ART was interrupted at the time of HSCT, HIV-1 RNA remained undetectable in serum. Proviral HIV-1 DNA became undetectable in PBMCs after full chimerism was achieved on posttransplant day 61. Despite relapse of AML nearly one year later, HIV-1 RNA and DNA remained undetectable. The patient underwent a second HSCT from the same donor and has had sustained remission of AML and HIV-1 infection ever since. As of this writing, the patient has been free of detectable HIV-1 infection for approximately eight years without any ART. Extensive sampling of blood, rectal tissue, lymph node, cerebrospinal fluid, and brain has failed to yield confirmable evidence of persistent HIV-1. Thus, for all intents and purposes, this patient may be considered cured of HIV-1 infection.
18. B
Successfully treated HIV-positive individuals have a normal life expectancy. Patients who started ART with a low CD4+cell count significantly improve their life expectancy if they have a good CD4+ cell count response and undetectable viral load.
7. Bone Marrow transplants from R5 negative donors has been tried since success of The Berlin...